A 2026 trial found short-term fasting around chemotherapy lowered insulin and improved response in ovarian cancer. Dr. Lena Suhaila, ND FABNO, explains.

Mistletoe therapy has decades of European research behind it and a 2023 Johns Hopkins phase I trial confirming safety and quality of life benefits. A naturopathic oncologist explains the mechanism, the evidence, and who it suits.

Dr. Lena Suhaila, ND, FABNO explains the metabolic science behind keto for cancer, what the research shows, how to start, and includes recipes and references.

Most breast cancer isn't inherited. A naturopathic oncologist maps the environmental exposures, from BPA to PFAS to glyphosate, that conventional care skips.

Soy is linked to lower breast cancer recurrence, but the protection depends on your gut microbiome. The equol story Western women rarely hear.

How diet, insulin, and breast cancer subtype shape recurrence risk. A naturopathic oncologist's evidence-based guide with sample days and references.

Cancer cells depend on glucose and exploit high insulin to grow. This is what metabolic oncology means in practice, and why food is a clinical tool, not an afterthought.

Your pathology report is the document that drives every treatment decision, and most patients never get it explained. Here is how to read yours, term by term, so you understand what the words mean and what to ask about next.

Two camps argue about HRT and most women feel stuck in the middle. The real answer depends on your biology, your genetics, and what your estrogen is actually doing in your body. A naturopathic oncologist walks through what to know before deciding.

How a naturopathic integrative oncologist works alongside chemotherapy: the metabolic, microbiome, and nervous system biology that shapes treatment.

You've read your pathology report. You showed up to your oncology appointments with questions, and the answers you got were about the tumor. What you didn't get answers about is everything else. Why this body. Why noe learned the staging, the markers, the protocol. What you didn't get answers about is everything else. Why this body. Why now. What your insulin has been doing. What your microbiome looks like. What your nervous system has been carrying. The science says these qu

The visit that ends before your real questions get asked. The medication added to manage the side effect of the last one. The sense the system isn't trying to make you well so much as managing how unwell you are. You haven't been imagining it. There are structural reasons.

Cancer cells run on a different fuel system, and ketogenic diets exploit that vulnerability. The cellular biology, the Warburg effect, and what the mechanism means.

ER-positive breast cancer treatment doesn’t just affect your body. It withdraws a primary chemical regulator from a brain that was built around it for thirty years. Here’s what that does to your serotonin, dopamine, memory, and mood, and what you can actually do about it.

A naturopathic integrative oncologist on the gaps that matter By Dr. Lena Suhaila, ND, FABNO There’s a phrase that circulates freely in oncology clinics, in tumor boards, in the brisk hallways of cancer centers: the patient tolerated the treatment well. It’s written in charts. It’s spoken in case reviews. It’s offered to families as reassurance. What it means, stripped of its clinical neutrality, is this: the treatment did what we needed it to do, and the body survived. Toler

Your oncologist chose the drug. But has anyone looked at whether your biology is positioned to respond to it? The answer is measurable, testable, and in many cases profoundly improvable.

Most people think of gut bacteria in terms of digestion and bloating. That framing is about two decades out of date. Your gut microbiome shapes how your immune system responds to cancer treatment, and the research behind that is no longer preliminary.

Cancer cells are voracious consumers of glucose. If your oncologist has never discussed your fasting insulin or blood sugar regulation as part of your cancer care, here is what the research says and why it matters.

You didn’t cause your cancer. And cancer doesn’t happen in a vacuum. This is how I work with the whole picture, in an integrative oncology practice that takes the time to actually see you.

Most cancer care targets the tumor. The metabolic approach asks what allowed the tumor to take hold in the first place. Here’s what integrative oncology actually addresses - cellular energy, insulin dynamics, mitochondrial function, and the nervous system - and why the terrain that made cancer possible is the same terrain that shapes recovery.